From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

Item
http://www.wikidata.org/entity/Q30665610
Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward.Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.Setting priorities in the health care sector - the case of oral anticoagulants in nonvalvular atrial fibrillation in DenmarkTransparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015.Who's afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic.Opinions and potential solutions regarding dissemination bias from funding agencies of biomedical research in Europe.Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion.
P2860

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

Item
http://www.wikidata.org/entity/Q30665610
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
From market access to patient ...... icals in 36 European countries
@ast
From market access to patient ...... icals in 36 European countries
@en
type
label
From market access to patient ...... icals in 36 European countries
@ast
From market access to patient ...... icals in 36 European countries
@en
prefLabel
From market access to patient ...... icals in 36 European countries
@ast
From market access to patient ...... icals in 36 European countries
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
From market access to patient ...... icals in 36 European countries
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P932